T ranscatheter arterial chemoembolization (TACE) is an excellent treatment modality for patients with hepatocellular carcinoma not amenable for surgery or percutaneous ablation therapies (1-4). The success of TACE depends on selectiveness and adequacy of chemoembolic agent delivery within the tumor vascular bed, preserving maximal liver cell function. This becomes more important in patients with mild to moderate liver cell dysfunction (Child Pugh B). Arterial phase computed tomography (CT) is done as part of planning TACE to locate tumor, map feeder vessels, and look for extrahepatic tumor arterial supply (1). Intraprocedural catheter placement is routinely guided by two-dimensional cine and digital subtraction angiography acquisitions; however, confident superselective catheter placement cannot be possible with such guidance alone in certain situations (2-4). This problem has been overcome with the advent of cone beam (C-arm) CT and vessel detection software; however, they are not widely available (2-5). The cases presented here illustrate application of an easily available and simple method that uses a portable ultrasonography (US) machine for distinguishing tumor vessels from normal vessels prior to embolization.
T ranscatheter arterial chemoembolization (TACE) is an excellent treatment modality for patients with hepatocellular carcinoma not amenable for surgery or percutaneous ablation therapies (1) (2) (3) (4) . The success of TACE depends on selectiveness and adequacy of chemoembolic agent delivery within the tumor vascular bed, preserving maximal liver cell function. This becomes more important in patients with mild to moderate liver cell dysfunction (Child Pugh B). Arterial phase computed tomography (CT) is done as part of planning TACE to locate tumor, map feeder vessels, and look for extrahepatic tumor arterial supply (1) . Intraprocedural catheter placement is routinely guided by two-dimensional cine and digital subtraction angiography acquisitions; however, confident superselective catheter placement cannot be possible with such guidance alone in certain situations (2) (3) (4) . This problem has been overcome with the advent of cone beam (C-arm) CT and vessel detection software; however, they are not widely available (2) (3) (4) (5) . The cases presented here illustrate application of an easily available and simple method that uses a portable ultrasonography (US) machine for distinguishing tumor vessels from normal vessels prior to embolization.
Case 1
A 63-year-old male patient was admitted to our hospital with complaints of right-sided abdominal pain, and significant loss of appetite and weight. He was a known case of cirrhosis, and had been treated conservatively. He had laboratory and imaging features of moderate liver cell failure and was categorized under Child Pugh class B. Triphasic CT showed cirrhosis with two closely related lesions, one 8.2 cm lesion in segments IV A and VIII, and one 4.2 cm lesion in segment IV A and B (Fig. 1a) . Arterial feeders could be traced from both left and right hepatic arteries. TACE was planned, and written informed consent was taken. Digital subtraction angiography (AlluraClarity, Philips Healthcare) of the common hepatic artery using a 5F SIM 2 catheter (Cook Inc.) showed tortuous vessels throughout the liver due to cirrhosis; and no definitive tumor blush could be identified (Fig. 1b) . A Progreat microcatheter (Terumo Medical Corp.) was used to super-selectively cannulate the suspected feeders. A mixture of 2 mL of patient's blood, 2 mL of saline, and 0.5 mL of air agitated between two Luer Lock syringes (Nipro Medical Corp.) across a three-way stopcock was injected through the microcatheter, and the liver was visualized using a convex US probe (C5-1 Broadband Curved Array, CX50 CompactXtreme Ultrasound System, Philips Healthcare). Hyperechoic blood-saline-bubble mixture flowing through the branches of the cannulated vessel and further into the tissue bed could be seen clearly. Adriamycin 75 mg (DOXOrubicinHCl, Bedford Laboratories) charged Hepaspheres (BioSphere Medical) prepared an hour prior to the pro-cedure were mixed with contrast solution for embolization. Injection into a left hepatic branch arising from the proper hepatic artery showed elevated reflection of the segment IV B lesion and also of a rim of adjacent hepatic parenchyma (Fig. 2a, 2b) , which was embolized. Injection into a branch of left hepatic artery showed elevated reflection of most of the central parts of the tumor (Fig.  2c, 2d ) and was embolized. Injection into the right hepatic artery showed enhanced reflectivity of peripheral parts of the larger tumor and significant amount of adjacent liver parenchyma (Fig. 2e) ; further selective cannulation into the anterior branch was performed, supply to peripheral parts of the larger tumor without adjacent significant liver parenchymal echo enhancement was confirmed by injection of agitated blood-saline-air mixture ( Fig. 2f ) and was embolized. CT done the next day showed absent tumor enhancement and filling of tumor vessels, with preserved blood flow to the rest of the liver parenchyma.
Case 2
A 75-year-old male patient with early cirrhosis was referred to the interventional radiology clinic for TACE of the liver lesion. The patient had raised alpha-fetoprotein (3059 ng/mL), and a CT (done elsewhere) detected subtle hypovascular lesion in segment VIII of right lobe of the liver with segmental portal vein thrombosis (Fig. 3a) . The patient had mild liver cell dysfunction (Child Pugh class A). CT also showed replaced right hepatic artery. The lesion could be seen on a screening US. TACE was planned and consent was taken. A 4F Cobra catheter (Cook Inc.) was used to cannulate the replaced right hepatic artery and further superselectively cannulate each of the two superiorly directed segmental branches. Angiography (AlluraClarity, Philips Healthcare) did not show a definite tumor blush, and two superiorly directed branches coursing towards the site of the lesion (Fig. 3b ). An agitated mixture of 2 mL patient's blood, 2 mL saline, and 0.5 mL air was injected through the catheter into each of the two superior segmental branches while the tumor was insonated continuously with a convex probe (C5-1 Broadband Curved Array, CX50 CompactXtreme Ultrasound System, Philips Healthcare). Injection into the medial branch showed blood-saline-bubble mixture induced increased reflectivity of normal parenchyma away from the lesion (Fig. 3c) and injection of the lateral branch showed elevated reflection of the parenchyma around the tumor and mildly of the tumor (due to hypovascular nature) confirming it to be the feeder vessel (Fig. 3d) ; the vascular bed of this feeder vessel was embolized with 75 mg Adriamycin (DOXOrubicinHCl, Bedford Laboratories) charged Hepaspheres (BioSphere Medical) prepared an hour before starting the procedure.
Discussion
TACE is a widely used treatment modality for hepatocellular carcinoma not amenable for surgery or percutaneous ablative treatments (1) (2) (3) (4) . Guidance to tumor vessels is usually by two-dimensional angiography, coupled with a prior knowledge of vascular anatomy based on an arterial phase multi-detector CT scan done before the procedure (2, 3). Accurate feeder vessel cannulation for embolization is required so that the intended dose of chemotherapeutic drug reaches the tumor and maximum residual liver parenchymal blood supply is preserved (2, 4) . Liver tissue preservation is especially important in patients who already have mild to moderate liver cell dysfunction, where inadvertent necrosis can land the patient in hepatic encephalopathy. However, accurate intubation of tumor feeder is sometimes not possible with two-dimensional angiography when the tumor is hypovascular, in the presence of enhancing nontumor nodules, overlapping vessels, or breathing artifacts, when lesions are small or located near the diaphragm, or background liver is cirrhotic resulting in tortuous vessels and inhomogeneous enhancement throughout the liver (2-4). These problems have been circumvented with the advent of cone beam or C-arm CT, which provides CT sections of the liver intraprocedurally, enabling confident labeling of a particular cannulated vessel as tumor feeder, when the CT is performed while injecting contrast through the catheter (2-5). Such a facility is not available widely (3), and performing an actual CT in between the procedure by shifting the patient to a CT facility is extremely cumbersome and fraught with possibility of puncture site complications and catheter displacements (3).
Contrast-enhanced US with an agitated mixture of saline, blood, and air provides
Main points
• Selectivity in transcatheter arterial chemoembolization (TACE) is very important to deliver the desired dose of chemotherapeutic agent to the tumor and to preserve function of normal liver tissue, especially in patients with borderline liver dysfunction.
• Finding the feeding vessel can be difficult with 2D angiography when there are too many overlapping vessels; if the tumor is avascular or very small (tumor blush might not be seen), close to diaphragm (cardiac and respiratory motion artifact obscuring tumor blush), or within cirrhotic liver (normal vessels might be tortuous); or when there are non-neoplastic enhancing lesions.
• Incorporating cone beam CT within the interventional suite enables intraprocedural CT scan of the liver while injecting contrast within a particular vessel, thereby allowing confident identification of the feeder; however, this facility is not commonly available.
• Contrast-enhanced US with agitated saline injection through catheter can be applied in nearly all cases to provide similar information, since hepatocellular tumors are almost always visible on US. that it passes through, because bubbles are more than million times effective at scattering sound waves with to red blood cells and hence enormously augment the blood pool signal (7), seen as bright echoes in two-dimensional US. This technique has popularly been used in echocardiography, especially for the detection of cardiac or extracardiac shunts (7) . Addition of blood to saline for agitating with air increases the viscosity, enabling more microbubbles to be trapped in the solution for a longer time (8, 9) and increasing visibility of the bubbles. The echo augmentation of the vascular bed is temporary as the bubbles either flow away to the pulmonary circulation to get excreted or get disrupted by ultrasound waves (10) . US contrast is prepared by agitating a mixture of 2 mL saline, 2 mL patient's blood, and 0.5 mL air between two Luer Lock syringes (to prevent accidental spray of blood) across a partially open (lever rotated 30°) three-way stopcock. The agitated mixture has to be used immediately after preparation since bubbles coalesce rapidly to form larger bubbles. This technique is very simple with requirements that are universally available; and it does not induce any additional complications (9) . Such successful usage of agitated blood-saline-air mixture for confident intraprocedural feeder vessel identification
Agitated saline sonography for feeder identification during TACE • 271 in TACE has not been previously described in the literature.
In conclusion, our experience showed that agitated blood-saline-air mixture transcatheter injection enables confident identification of tumor feeder intraprocedurally during TACE with no additional risk.
